Stay updated on BLU-5937 in Refractory Chronic Cough Clinical Trial
Sign up to get notified when there's something new on the BLU-5937 in Refractory Chronic Cough Clinical Trial page.

Latest updates to the BLU-5937 in Refractory Chronic Cough Clinical Trial page
- CheckyesterdayChange DetectedThe Study Details page for NCT05600777 shows no additions or deletions; the content appears unchanged.SummaryDifference0.0% 
- Check8 days agoNo Change Detected
- Check22 days agoChange DetectedSignificant expansion of investigational site locations (now 242) with new addresses and principal investigators; older count and dates removed.SummaryDifference9% 
- Check30 days agoChange DetectedUpdated contact details and version: added new support phone numbers and email, and updated revision from v3.0.2 to v3.2.0.SummaryDifference0.0% 
- Check31 days agoChange DetectedUpdate: page revision to v3.1.0 and expanded contact details (new phone numbers and email) replacing v3.0.2.SummaryDifference0.0% 
- Check38 days agoChange DetectedCore content about drug safety and quality terms has been removed.SummaryDifference0.1% 
- Check45 days agoChange DetectedThe page now lists 219 locations with several new sites (e.g., Orpington UK; Anderson SC; Leshan, Sichuan) and some withdrawals (Fürstenwalde, Cypress TX), plus updates to site details (St. Louis ZIP 63105) and new investigators (Hailong Wei, Meilin Jin) alongside removed names. A new US/EU contact section and a revision marker v3.0.2 posted on 2025-09-08, with an estimated last update label, accompany the change.SummaryDifference3% 
Stay in the know with updates to BLU-5937 in Refractory Chronic Cough Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BLU-5937 in Refractory Chronic Cough Clinical Trial page.